Endo Pharmaceuticals Holdings Inc. [ENDP]

Peter Lankau, Chief Executive Officer of Endo Pharmaceuticals Holdings Inc., presides over the closing bell.

Monday August 27, 2007
from Nasdaq MarketSite
in New York's Times Square

Additional Photographs & Reprint Permissions
Archived MarketSite Events | Summary Quote

Peter Lankau, Chief Executive Officer of Endo Pharmaceuticals Holdings Inc., presides over the closing bell.

Headquartered in CHADDS FORD, PA, Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of both branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at www.endo.com.

Reprints

Click for larger pictures of the NASDAQ MarketSite.

Additional Photographs for 08/27/2007

Download Hi-Res Quality Photo of this NASDAQ Market Open
- Pictured: Peter Lankau, Chief Executive Officer of Endo Pharmaceuticals Holdings Inc., presides over the closing bell.
Organizations interested in obtaining NASDAQ-listed company bell ringing ceremony photographs for press purposes, must first receive approval from the listed company before requesting photographs from NASDAQ. Please provide the company contact information from whom you received approval to Jolene Libretto at Jolene.Libretto@nasdaq.com. Kindly credit © 2007, The Nasdaq Stock Market, Inc. Reprinted with permission.